VM is getting rerated after PEA valued at $344MVoyageur Pharmaceuticals Announces IRR of 137% and NPV of $344 Million from Preliminary Economic Assessment for the Frances Creek Pharmaceutical Barium Project
News Release – Calgary, Alberta - TheNewswire – January 11, 2022 - Voyageur Pharmaceuticals Ltd. (“Voyageur” or the “Company”) (TSXV:VM) i
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.010 CAD
−1.71 M CAD
0.00 CAD
146.83 M
About VOYAGEUR PHARMACEUTICALS LTD
Sector
Industry
CEO
Brent Willis
Website
Headquarters
Calgary
Founded
2008
FIGI
BBG00263KPN9
Voyageur Pharmaceuticals Ltd. engages in exploring and development of barite, iodine, and fullerene Active Pharmaceutical Ingredient (API) minerals. It focuses in developing barium contrast radiographic suspension products for the pharmaceutical industry. The company was founded by Brent Willis on July 23, 2008 and is headquartered in Calgary, Canada.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of VM is 0.150 CAD — it has decreased by −11.11% in the past 24 hours. Watch VOYAGEUR PHARMACEUTICALS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange VOYAGEUR PHARMACEUTICALS LTD stocks are traded under the ticker VM.
VM stock has fallen by −3.03% compared to the previous week, the month change is a 10.34% rise, over the last year VOYAGEUR PHARMACEUTICALS LTD has showed a 150.00% increase.
VM stock is 13.33% volatile and has beta coefficient of −2.44. Track VOYAGEUR PHARMACEUTICALS LTD stock price on the chart and check out the list of the most volatile stocks — is VOYAGEUR PHARMACEUTICALS LTD there?
Today VOYAGEUR PHARMACEUTICALS LTD has the market capitalization of 25.69 M, it has increased by 5.88% over the last week.
Yes, you can track VOYAGEUR PHARMACEUTICALS LTD financials in yearly and quarterly reports right on TradingView.
VOYAGEUR PHARMACEUTICALS LTD is going to release the next earnings report on Apr 25, 2025. Keep track of upcoming events with our Earnings Calendar.
VM net income for the last quarter is −458.51 K CAD, while the quarter before that showed −359.13 K CAD of net income which accounts for −27.67% change. Track more VOYAGEUR PHARMACEUTICALS LTD financial stats to get the full picture.
No, VM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VOYAGEUR PHARMACEUTICALS LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VOYAGEUR PHARMACEUTICALS LTD technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VOYAGEUR PHARMACEUTICALS LTD stock shows the buy signal. See more of VOYAGEUR PHARMACEUTICALS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.